基于泛血管病概念对虫类药应用的思考

高想; 於悦; 郑晓丹; 张锋莉; 盛炜

doi:10.14148/j.issn.1672-0482.2022.0898

基于泛血管病概念对虫类药应用的思考

doi: 10.14148/j.issn.1672-0482.2022.0898

高想^{1, 2, ,},
於悦¹,
郑晓丹^{1, 2},
张锋莉¹,
盛炜¹

1.
南京中医药大学南通附属医院, 江苏南通 226001
2.
国家中医药管理局国医大师朱良春学术经验传承研究室, 江苏南通 226001

基金项目:

南通市科技局社会民生科技计划 MS12021036

详细信息

作者简介:
高想, 主任中医师, 硕士生导师，国医大师朱良春学术继承人，国家中医药管理局国医大师朱良春学术经验传承研究室副主任，南京中医药大学南通附属医院心内科学科带头人。长期从事中医和中西医结合内科临床，对心血管疾病和虫类药物有较深入的研究。发表论文100余篇，出版专著(主编、副主编)11部，主持或主要参与省、市科研课题10余项《朱良春虫类药的应用》(副主编)获中华中医药学会学术著作一等奖(2016)、《虫类药的应用历史与展望》入选“中国科技期刊卓越行动计划项目”第一届《中华中医药杂志》百篇高影响学术论文(2020)

通讯作者:
高想，男，主任中医师，主要从事心血管疾病临床和虫类药研究，E-mail：ntgx1964@163.com

中图分类号: R287
计量
- 文章访问数: 71
- HTML全文浏览量: 7
- PDF下载量: 23
- 被引次数: 0
出版历程
- 收稿日期: 2022-06-16
- 网络出版日期: 2022-10-25
- 发布日期: 2022-10-10

Reflections on the Application of Insect Medicine Based on the Concept of Panvascular Diseases

GAO Xiang^{1, 2
, ,},
YU Yue¹,
ZHENG Xiao-dan^{1, 2},
ZHANG Feng-li¹,
SHENG Wei¹

1.
Nantong TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Nantong 226001, China
2.
National Master Zhu Liangchun's Academic Experience Inheritance Office, State Administration of Traditional Chinese Medicine, Nantong 226001, China

摘要

摘要: 泛血管病是以血管病变为共同病理特征的一组系统性血管疾病，动脉粥样硬化(AS)是泛血管病的共同病理基础，认识血管性疾病的发生、发展规律及特征，对于泛血管疾病的防治，具有十分重要的意义。痰、瘀、毒、风是泛血管病AS发生的共同致病因素，其中痰瘀互结是其核心病机，浊毒化风是疾病演变、事件发生的重要环节。虫类药以其攻逐走窜，搜剔疏利，而具有独特的祛痰化瘀，泄浊通络功效，系统研究虫类药物的抗AS作用，有利于拓展泛血管病的治疗思路。
- 泛血管病 /
- 发病机制 /
- 虫类药
Abstract: Panvascular diseases are a group of systemic vascular diseases with common pathological features of vasculopathy. Atherosclerosis (AS) is the common pathological basis of panvascular diseases, so it is of great importance to understand the law of occurrence and development, as well as the characteristics of vascular diseases for the prevention and treatment of panvascular diseases. The study considers the phlegm, stasis, toxicity, and wind as the common pathogenic factors in the occurrence of panvascular disease AS, among which the binding of phlegm and stasis is the core pathogenesis, while the pathogenic wind transformed by turbidity and toxicity is the important links in the disease occurrence and development. Insect medicine is known for its ability to expel and drive away pathogenic factors with its unique efficacy in dispelling phlegm, removing stasis, draining turbidity, and unblocking collaterals, so it may begin a new chapter in the treatment of panvascular diseases.
- panvascular diseases /
- pathogenesis /
- insect medicines

HTML全文

参考文献(45)

[1]	杨靖, 王克强, 霍勇, 等. 泛血管疾病综合防治科学声明[J]. 中国循环杂志, 2019, 34(11): 1041-1046. doi: 10.3969/j.issn.1000-3614.2019.11.001 YANG J, WANG KQ, HUO Y, et al. Scientific statement for the prevention and treatment of panvascular disease[J]. Chin Circ J, 2019, 34(11): 1041-1046. doi: 10.3969/j.issn.1000-3614.2019.11.001
[2]	李中梓. 医宗必读[M]. 上海: 上海科学技术出版社, 1959: 290. LI ZZ. Required Readings from the Medical Ancestors[M]. Shanghai: Shanghai scientific and technical publishers, 1959: 290.
[3]	张丽, 赵珈艺, 金香兰, 等. 脑卒中高危伴颈动脉硬化人群内脏脂肪指数、脂质蓄积指数与中医证候的相关性研究[J]. 天津中医药, 2021, 38(5): 589-595. https://www.cnki.com.cn/Article/CJFDTOTAL-TJZY202105013.htm ZHANG L, ZHAO JY, JIN XL, et al. Correlation between visceral fat index, lipid accumulation index and syndromes of traditional Chinese medicine in high risk of stroke population with carotid atherosclerosis[J]. Tianjin J Tradit Chin Med, 2021, 38(5): 589-595. https://www.cnki.com.cn/Article/CJFDTOTAL-TJZY202105013.htm
[4]	唐容川. 血证论[M]. 上海: 上海人民出版社, 1977. TANG RC. Treatise on Blood Syndromes[M]. Shanghai: Shanghai people's publishing house, 1977.
[5]	朱震亨. 丹溪心法[M]. 上海: 上海科学技术出版社, 1959: 77. ZHU ZH. Teachings of Zhu Dan-xi[M]. Shanghai: Shanghai scientific and technical publishers, 1959: 77.
[6]	张艳, 杨关林, 于睿, 等. 动脉粥样硬化中医虚瘀痰毒病因病机实质研究探讨[J]. 时珍国医国药, 2007, 18(6): 1513-1514. doi: 10.3969/j.issn.1008-0805.2007.06.145 ZHANG Y, YANG GL, YU R, et al. Discussion on essence of arteriosclerosis from pathogeny and pathogenesis of traditional Chinese medicine about "qi" deficiency, blood stasis, phlegm and toxin[J]. Lishizhen Med Mater Med Res, 2007, 18(6): 1513-1514. doi: 10.3969/j.issn.1008-0805.2007.06.145
[7]	李玉洁, 杨庆, 翁小刚, 等. 活血、解毒: 中药干预AS炎症反应的探索与尝试[J]. 中国药理学通报, 2010, 26(5): 577-580. https://www.cnki.com.cn/Article/CJFDTOTAL-YAOL201005009.htm LI YJ, YANG Q, WENG XG, et al. Activating blood circulation anddisintoxication—a new exploration in atherosclarosis intervention by Chinese medicine[J]. Chin Pharmacol Bull, 2010, 26(5): 577-580. https://www.cnki.com.cn/Article/CJFDTOTAL-YAOL201005009.htm
[8]	苏文全, 金荣, 耿运玲, 等. 四妙勇安汤抑制ApoE^-/-小鼠动脉粥样硬化斑块炎症反应的影响[J]. 中医药学报, 2021, 49(8): 12-16. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYXB202108004.htm SU WQ, JIN R, GENG YL, et al. Effect of Simiao Yong'an Decoction on inflammatory responses of atherosclerotic plaque in ApoE^-/- mice[J]. Acta Chin Med Pharmacol, 2021, 49(8): 12-16. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYXB202108004.htm
[9]	李兆钰, 丁书文, 马度芳, 等. 基于心系疾病热毒学说探讨中医药抗炎治疗动脉粥样硬化[J]. 中华中医药杂志, 2021, 36(7): 3916-3920. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY202107036.htm LI ZY, DING SW, MA DF, et al. Discussion on the anti-inflammatory treatment of atherosclerosis with traditional Chinese medicine based on the heat-toxicity theory in cardiovascular disease[J]. China J Tradit Chin Med Pharm, 2021, 36(7): 3916-3920. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY202107036.htm
[10]	王显, 胡大一, 沙鸥. 中医络风内动证的病变特征和炎症标志物的检测[J]. 心脏杂志, 2008, 20(5): 619-621, 626. https://www.cnki.com.cn/Article/CJFDTOTAL-XGNZ200805036.htm WANG X, HU DY, SHA O. Angiographic morphology of coronary artery lesions and level of plasma inflammatory markers in patients with endogenous collateral wind[J]. Chin Heart J, 2008, 20(5): 619-621, 626. https://www.cnki.com.cn/Article/CJFDTOTAL-XGNZ200805036.htm
[11]	付焕杰, 刘志超, 王铭扬, 等. 浅议风药在冠脉血运重建术后胸痛论治中的应用[J]. 中国中医急症, 2022, 31(4): 641-644. doi: 10.3969/j.issn.1004-745X.2022.04.020 FU HJ, LIU ZC, WANG MY, et al. Application of "wind medicine" in the treatment of chest pain after revascularization[J]. J Emerg Tradit Chin Med, 2022, 31(4): 641-644. doi: 10.3969/j.issn.1004-745X.2022.04.020
[12]	灵枢经[M]. 北京: 商务印书馆, 1954: 127. The Spiritual Pivot[M]. Beijing: The commercial press, 1954: 127.
[13]	王旭东. 巢元方医学全书[M]. 北京: 中国中医药出版社, 2018: 154. WANG XD. Complete Medical Works from Chao Yuan-fang[M]. Beijing: China press of traditional Chinese medicine, 2018: 154.
[14]	柳宝诒. 柳选四家医案[M]. 上海: 上海卫生出版社, 1957: 124. LIU BY. Liu's Selected Case Records of Four Physicians[M]. Shanghai: Shanghai medical publishing house, 1957: 124.
[15]	王纶. 明医杂著[M]. 北京: 中国中医药出版社, 2009: 126. WANG L. Miscellaneous Writings of Famous Physicians of the Ming Dynasty[M]. Beijing: China press of traditional Chinese medicine, 2009: 126.
[16]	吴昆. 医方考[M]. 北京: 中国中医药出版社, 1998: 9. WU K. Investigations of Medical Formulas[M]. Beijing: China press of traditional Chinese medicine, 1998: 9.
[17]	李翠娟, 巩振东, 胡勇, 等. 雷忠义运用痰瘀相关理论治疗冠心病经验[J]. 中医杂志, 2022, 63(4): 312-314, 331. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ202204003.htm LI CJ, GONG ZD, HU Y, et al. LEI Zhongyi's experience in treating coronary heart disease with phlegm and stasis related theory[J]. J Tradit Chin Med, 2022, 63(4): 312-314, 331. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ202204003.htm
[18]	魏勇军. 高社光从痰瘀论治中风病经验[J]. 中医杂志, 2012, 53(5): 379-381. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ201205007.htm WEI YJ. Gao Sheguang's experience in treating stroke disease from the theory of phlegm and stasis[J]. J Tradit Chin Med, 2012, 53(5): 379-381. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ201205007.htm
[19]	陈洁, 蔡宏文, 缪静, 等. 丹蒌片抗痰瘀互结型动脉粥样硬化大鼠炎症反应及机制[J]. 中国中西医结合杂志, 2016, 36(6): 703-708. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXJ201606015.htm CHEN J, CAI HW, MIAO J, et al. Danlou Tablet fought against inflammatory reaction in atherosclerosis rats with intermingled phlegm and blood stasis syndrome and its mechanism study[J]. Chin J Integr Tradit West Med, 2016, 36(6): 703-708. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXJ201606015.htm
[20]	蔡宏文, 缪静, 周鑫斌, 等. 痰瘀同治方调控PPARγ/NF-κB通路对大鼠动脉粥样硬化斑块内血管新生的影响[J]. 中国中西医结合杂志, 2017, 37(5): 579-583. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXJ201705016.htm CAI HW, MIAO J, ZHOU XB, et al. Effect of Tanyu Tongzhi recipe on angiogenesis in atherosclerosis plaque rats by regulating PPARγ/NF-κB pathways[J]. Chin J Integr Tradit West Med, 2017, 37(5): 579-583. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXJ201705016.htm
[21]	蔡宏文, 李昕遥, 周鑫斌, 等. 痰瘀同治方调控自噬对心肌缺血区和动脉粥样硬化斑块内血管新生不同作用的实验研究[J]. 浙江中医药大学学报, 2020, 44(7): 652-656. https://www.cnki.com.cn/Article/CJFDTOTAL-BHON202007013.htm CAI HW, LI XY, ZHOU XB, et al. Experimental study on the different effects of Tanyu Tongzhi recipe regulating autophagy on neovascularization in myocardial ischemic area and atherosclerotic plaque[J]. J Zhejiang Chin Med Univ, 2020, 44(7): 652-656. https://www.cnki.com.cn/Article/CJFDTOTAL-BHON202007013.htm
[22]	张山雷. 中风斠诠[M]. 福州: 福建科学技术出版社, 2007: 22. ZHANG SL. Commentary on Stroke Diseases[M]. Fuzhou: Fujian scientific and technical publishers, 2007: 22.
[23]	杨利, 黄燕, 蔡业峰, 等. 1418例中风患者痰瘀证候分布和演变规律探析[J]. 辽宁中医杂志, 2004, 31(6): 459-460. https://www.cnki.com.cn/Article/CJFDTOTAL-LNZY200406011.htm YANG L, HUANG Y, CAI YF, et al. The law of distribution and development of phlegm-stasis syndromes in 1418 stroke patients[J]. Liaoning J Tradit Chin Med, 2004, 31(6): 459-460. https://www.cnki.com.cn/Article/CJFDTOTAL-LNZY200406011.htm
[24]	杨继, 张垚, 张运娇, 等. 通心络胶囊联合西医常规治疗不稳定型心绞痛疗效与安全性的Meta分析[J]. 药物评价研究, 2021, 44(4): 830-847. https://www.cnki.com.cn/Article/CJFDTOTAL-YWPJ202104026.htm YANG J, ZHANG Y, ZHANG YJ, et al. Meta-analysis of efficacy and safety of Tongxinluo Capsule combined with conventional western medicine in treatment of unstable angina pectoris[J]. Drug Eval Res, 2021, 44(4): 830-847. https://www.cnki.com.cn/Article/CJFDTOTAL-YWPJ202104026.htm
[25]	高想, 朱良春. 虫类药的应用历史与展望[J]. 中华中医药杂志, 2010, 25(6): 807-809. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201006003.htm GAO X, ZHU LC. Prospects and research situation of insect-drugs[J]. China J Tradit Chin Med Pharm, 2010, 25(6): 807-809. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201006003.htm
[26]	唐容川. 本草问答评注[M]. 太原: 山西科学教育出版社, 1991: 83. TANG RC. Commentary on the Questions and Answers on the Materia Medica[M]. Taiyuan: Shanxi scientific and educational publishers, 1991: 83.
[27]	沈鲁珍, 叶天士, 缪宜亭. 三家医案合刻沈氏医案[M]. 上海: 上海科学技术出版社, 2010: 37. SHEN LZ, YE TS, MIAO YT. The Bound Volume of Shen's Medical Cases from Three Medical Physicians[M]. Shanghai: Shanghai scientific and technical publishers, 2010: 37.
[28]	叶天士. 临证指南医案[M]. 上海: 第二军医大学出版社, 2006. YE TS. Case Records as a Guide to Clinical Practice[M]. Shanghai: Second military medical university press, 2006.
[29]	汪绂. 医林纂要探源[M]. 北京: 中国中医药出版社, 2015: 245. WANG F. Collection of Investigations from the Medical Community[M]. Beijing: China press of traditional Chinese medicine, 2015: 245.
[30]	李中梓. 本草通玄[M]. 北京: 中国中医药出版社, 2015: 94. LI ZZ. Penetrating the Mysteries of the Materia Medica[M]. Beijing: China press of traditional Chinese medicine, 2015: 94.
[31]	张锡纯. 医学衷中参西录[M]. 石家庄: 河北人民出版社, 1957: 383-384. ZHANG XC. Records of Chinese Medicine with Reference to Western Medicine[M]. Shijiazhuang: Hebei people's publishing house, 1957: 383-384.
[32]	皇甫中. 明医指掌[M]. 北京: 中国中医药出版社, 1997: 20. HUANG FZ. Guide from Famous Physicians of the Ming Dynasty[M]. Beijing: China press of traditional Chinese medicine, 1997: 20.
[33]	黄宫绣. 本草求真[M]. 北京: 人民卫生出版社, 1987: 133. HUANG GX. Seeking Accuracy in the Materia Medica[M]. Beijing: People's medical publishing house, 1987: 133.
[34]	严西亭, 施澹宁, 洪缉庵. 得配本草[M]. 上海: 上海科学技术出版社, 1958: 202. YAN XT, SHI DN, HONG JA. Materia Medica of Combinations[M]. Shanghai: Shanghai scientific and technical publishers, 1958: 202.
[35]	江玉娟, 司秋菊, 张艳慧, 等. 大黄蟅虫丸对动脉粥样硬化模型大鼠胰岛素样生长因子表达的影响[J]. 中国老年学杂志, 2009, 29(1): 39-41. https://www.cnki.com.cn/Article/CJFDTOTAL-ZLXZ200901019.htm JIANG YJ, SI QJ, ZHANG YH, et al. Effect of Dahuang Zhechong pill on the level of insulin-like growth factor-1 in atherosclerotic mice[J]. Chin J Gerontol, 2009, 29(1): 39-41. https://www.cnki.com.cn/Article/CJFDTOTAL-ZLXZ200901019.htm
[36]	周欣欣, 李娟, 高雅, 等. 补阳还五汤黄芪不同配比组方调控动脉粥样硬化炎性反应的分子机制研究[J/OL]. 中华中医药学刊, 2022: 1-10. http://kns.cnki.net/kcms/detail/21.1546.R.20220411.1628.020.html. ZHOU XX, LI J, GAO Y, et al. Study on the molecular mechanism of Buyang Huanwu Decoction with different dosages of Astragalus regulating the inflammatory response of atherosclerosis[J/OL]. Chin Arch Tradit Chin Med, 2022: 1-10. http://kns.cnki.net/kcms/detail/21.1546.R.20220411.1628.020.html.
[37]	刘斌. 通窍活血汤加减对椎-基底动脉供血不足性眩晕(瘀血阻窍型)的疗效观察[D]. 哈尔滨: 黑龙江中医药大学, 2015. LIU B. Clinical efficacy basilar artery insufficiency Vertigo-Tongqiaohuoxue decoction (orifice stasis type) of vertebral[D]. Harbin: Heilongjiang University of Chinese Medicine, 2015.
[38]	高想, 於悦, 郑晓丹, 等. 章朱学派虫类药研究的贡献[J]. 南京中医药大学学报(社会科学版), 2019, 20(4): 226-230, 287. https://www.cnki.com.cn/Article/CJFDTOTAL-NJZD201904003.htm GAO X, YU Y, ZHENG XD, et al. Zhang-Zhu school's contribution on insect medicine research[J]. J Nanjing Univ Tradit Chin Med Soc Sci Ed, 2019, 20(4): 226-230, 287. https://www.cnki.com.cn/Article/CJFDTOTAL-NJZD201904003.htm
[39]	郑晓丹, 高想, 朱建华. 朱良春教授"虫蚁搜剔通络法在心系病中的应用"学术经验浅析[J]. 中西医结合心脑血管病杂志, 2019, 17(15): 2390-2394. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYYY201915041.htm ZHENG XD, GAO X, ZHU JH. An analysis of the academic experience of Professor Zhu Liangchun on the method application of unblocking collaterals by insects and ants in cardiac diseases[J]. Chin J Integr Med on Cardio-Cerebrovas Dis, 2019, 17(15): 2390-2394. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYYY201915041.htm
[40]	郑晓丹, 解金洪, 蔡娟, 等. 双降汤联合阿托伐他汀对颈动脉粥样硬化患者斑块的影响及其机制研究[J]. 南京中医药大学学报, 2018, 34(5): 456-460. https://www.cnki.com.cn/Article/CJFDTOTAL-NJZY201805007.htm ZHENG XD, XIE JH, CAI J, et al. Effect of Shuangjiang Decoction on carotid atherosclerotic plaque[J]. J Nanjing Univ Tradit Chin Med, 2018, 34(5): 456-460. https://www.cnki.com.cn/Article/CJFDTOTAL-NJZY201805007.htm
[41]	龚宝莹, 郭建文, 周粤湘, 等. 浅析章朱学派治疗中风的学术经验[J]. 中医杂志, 2020, 61(3): 254-256. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ202003023.htm GONG BY, GUO JW, ZHOU YX, et al. Analysis of the academic experience of ZHANG & ZHU school in treating stroke[J]. J Tradit Chin Med, 2020, 61(3): 254-256. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ202003023.htm
[42]	王金贺, 王托资, 姜德友. 姜德友运用虫类药治疗心脑血管疾病经验[J]. 中华中医药杂志, 2020, 35(8): 3962-3965. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY202008043.htm WANG JH, WANG TZ, JIANG DY. JIANG De-you's experience in treating cardiovascular and cerebrovascular diseases with insect drug[J]. China J Tradit Chin Med Pharm, 2020, 35(8): 3962-3965. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY202008043.htm
[43]	张鹤, 张花平, 张楠, 等. 虫类药联合贝前列素治疗下肢动脉硬化闭塞症效果及安全性观察[J]. 解放军医药杂志, 2021, 33(7): 105-109. https://www.cnki.com.cn/Article/CJFDTOTAL-HBGF202107025.htm ZHANG H, ZHANG HP, ZHANG N, et al. Clinical efficacy and safety of insect drugs combined with beraprost in treatment of patients with lower extremity arteriosclerosis obliterans[J]. Med Pharm J Chin PLA, 2021, 33(7): 105-109. https://www.cnki.com.cn/Article/CJFDTOTAL-HBGF202107025.htm
[44]	徐文强, 杨莹, 彭井华, 等. 葛根与地龙联合应用对大鼠脑缺血再灌注损伤的预防作用及其机制探讨[J]. 山东医药, 2016, 56(15): 41-43. https://www.cnki.com.cn/Article/CJFDTOTAL-SDYY201615013.htm XU WQ, YANG Y, PENG JH, et al. Prevention of cerebral ischemia-reperfusion injury in rats by the combined application of Radix Puerariae Lobatae and Pheretima and its mechanism[J]. Shandong Med J, 2016, 56(15): 41-43. https://www.cnki.com.cn/Article/CJFDTOTAL-SDYY201615013.htm
[45]	李瑶, 王达洋, 王显. 从"络风内动"病机学说探讨支架内再狭窄和支架内血栓形成的防治[J]. 中西医结合心脑血管病杂志, 2022, 20(2): 361-364. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYYY202202040.htm LI Y, WANG DY, WANG X. Prevention and treatment of in-stent restenosis and in-stent thrombosis from the theory of "endogenous collateral wind"[J]. Chin J Integr Med on Cardio-Cerebrovas Disease, 2022, 20(2): 361-364. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYYY202202040.htm